Skip to main content
. 2017 Jun 14;7(6):e015447. doi: 10.1136/bmjopen-2016-015447

Figure 3.

Figure 3

Patient pathway diagram to illustrate the flow for men who have sex with men (MSM) under (A) current care and (B) antimicrobial resistance (AMR) point-of-care test (POCT). In scenario A, all diagnosed cases are treated with ceftriaxone plus azithromycin. In scenario B, diagnosed cases are treated according to resistance profile: AMR cases with ceftriaxone plus azithromycin; non-AMR with ciprofloxacin. Numbers of AMR and non-AMR infection are based on current levels of ciprofloxacin resistance observed in Gonococcal Resistance to Antimicrobial Surveillance Program surveillance data, 2014. Illustrated based on 100 000 MSM attending a genitourinary medicine clinic.